The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of homologous recombination repair (HRR) gene mutation status on treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US).
 
Pedro C. Barata
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - Bayer (Inst); Caris Life Sciences (Inst); Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Merck (Inst); Pfizer (Inst)
 
Ella X. Du
Employment - Analysis Group
Consulting or Advisory Role - Pfizer (Inst)
 
Hongbo Yang
Employment - Analysis Group
Consulting or Advisory Role - Pfizer (Inst)
 
Chunyi Xu
Employment - Analysis Group
Consulting or Advisory Role - Pfizer (Inst)
 
Helen Guo
Employment - Analysis Group
Consulting or Advisory Role - Pfizer (Inst)
 
Caroline Cui
Employment - Analysis Group
Consulting or Advisory Role - Pfizer (Inst)
 
Jonathan Nazari
Employment - Pfizer
 
Alexander Niyazov
Employment - Pfizer